74 results Louis Bidaine Associate Brussels Philippe Campolini Partner Brussels Jan Truijens Martinez Counsel Amsterdam Vince Van der Wangen Associate Brussels Ignace Vernimme Partner Brussels Nathan Thys Junior Associate Brussels Mari Muzashvili Junior Associate Brussels Stibbe advises SleepScore Labs Stibbe advised SleepScore Labs on the acquisition of Sleep.ai, a Netherlands-based digital health company. Anya Murphy Junior Associate Brussels Ignace Vernimme and Philippe Campolini authored the article “Covid-19: the Belgian perspective” Ignace Vernimme and Philippe Campolini contributed to the 2020 edition of the IBA Healthcare and Life Sciences Law Committee e-bulletin. Stibbe represents the bankruptcy trustees of Amsterdam hospital MC Slotervaart in dispute with the City of Amsterdam Stibbe represented the bankruptcy trustees of the Amsterdam hospital MC Slotervaart in proceedings against the City of Amsterdam, centred on the City’s demand that the bankruptcy trustees investigate whether there were any irregularities prior to the ban Stibbe advises DW Healthcare Partners Stibbe advised DW Healthcare Partners, a private equity investment firm, on the acquisition of CEFALY Technology, a company active in the healthcare sector. Stibbe advises Aedifica Stibbe advised Aedifica on the acquisition of a healthcare residence for the elderly in Franeker (Friesland). Stibbe advises Agendia Stibbe advised Agendia on securing a $35 million investment from funds managed by Athyrium Capital Management. Stibbe advises Canon Medical Systems Stibbe advised Canon Medical Systems on the acquisition of Dutch medical equipment manufacturer Fysicon. Stibbe advises Aedifica Stibbe advises Aedifica on the acquisition of a care residence to be constructed in Bosch en Duin (municipality of Zeist). Stibbe advises Aedifica Stibbe advises Aedifica on the acquisition of three healthcare residences for the elderly at Leiden, Oss and Amersfoort. The three residences are operated by ECR/Blueprint Group. Stibbe advises on the equity offering of ProQR Stibbe advised the joint bookrunners Citigroup, Evercore ISI and RBC Capital Markets and the co-managers on the $104.1 million equity offering of ProQR Therapeutics N.V. ("ProQR"). Pagination Previous page Page 1 Current page 2 Page 3 Page 4 Next page
Stibbe advises SleepScore Labs Stibbe advised SleepScore Labs on the acquisition of Sleep.ai, a Netherlands-based digital health company.
Ignace Vernimme and Philippe Campolini authored the article “Covid-19: the Belgian perspective” Ignace Vernimme and Philippe Campolini contributed to the 2020 edition of the IBA Healthcare and Life Sciences Law Committee e-bulletin.
Stibbe represents the bankruptcy trustees of Amsterdam hospital MC Slotervaart in dispute with the City of Amsterdam Stibbe represented the bankruptcy trustees of the Amsterdam hospital MC Slotervaart in proceedings against the City of Amsterdam, centred on the City’s demand that the bankruptcy trustees investigate whether there were any irregularities prior to the ban
Stibbe advises DW Healthcare Partners Stibbe advised DW Healthcare Partners, a private equity investment firm, on the acquisition of CEFALY Technology, a company active in the healthcare sector.
Stibbe advises Aedifica Stibbe advised Aedifica on the acquisition of a healthcare residence for the elderly in Franeker (Friesland).
Stibbe advises Agendia Stibbe advised Agendia on securing a $35 million investment from funds managed by Athyrium Capital Management.
Stibbe advises Canon Medical Systems Stibbe advised Canon Medical Systems on the acquisition of Dutch medical equipment manufacturer Fysicon.
Stibbe advises Aedifica Stibbe advises Aedifica on the acquisition of a care residence to be constructed in Bosch en Duin (municipality of Zeist).
Stibbe advises Aedifica Stibbe advises Aedifica on the acquisition of three healthcare residences for the elderly at Leiden, Oss and Amersfoort. The three residences are operated by ECR/Blueprint Group.
Stibbe advises on the equity offering of ProQR Stibbe advised the joint bookrunners Citigroup, Evercore ISI and RBC Capital Markets and the co-managers on the $104.1 million equity offering of ProQR Therapeutics N.V. ("ProQR").